Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Ernsting

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 23, 2011
Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicinTatsuaki Tagami, Mark J Ernsting, Shyh-Dar Li
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 7, 2011
Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro systemTatsuaki Tagami, Mark J Ernsting, Shyh-Dar Li
Journal of Biomedical Materials Research. Part A|June 15, 2007
Human monocyte adhesion onto RGD and PHSRN peptides delivered to the surface of a polycarbonate polyurethane using bioactive fluorinated surface modifiersMark J Ernsting, Rosalind S Labow, J Paul Santerre
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 1, 2013
Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticlesMark J Ernsting, Mami Murakami, Aniruddha Roy, et al.
Biomaterials|March 31, 2015
A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumorsAniruddha Roy, Mark J Ernsting, Elijus Undzys, et al.
Molecular Pharmaceutics|October 25, 2013
Thermosensitive liposomes for the delivery of gemcitabine and oxaliplatin to tumorsJonathan P May, Mark J Ernsting, Elijus Undzys, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 17, 2012
A thermosensitive liposome prepared with a Cu²⁺ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacyTatsuaki Tagami, Jonathan P May, Mark J Ernsting, et al.
Bioconjugate Chemistry|October 22, 2011
Synthetic modification of carboxymethylcellulose and use thereof to prepare a nanoparticle forming conjugate of docetaxel for enhanced cytotoxicity against cancer cellsMark J Ernsting, Wei-Lun Tang, Noah MacCallum, et al.
International Journal of Pharmaceutics|May 24, 2014
Docetaxel-carboxymethylcellulose nanoparticles display enhanced anti-tumor activity in murine models of castration-resistant prostate cancerBryan Hoang, Mark J Ernsting, Mami Murakami, et al.
Biomaterials|November 15, 2011
Preclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse modelsMark J Ernsting, Wei-Lun Tang, Noah W MacCallum, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 23, 2011
Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicinTatsuaki Tagami, Mark J Ernsting, Shyh-Dar Li
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 7, 2011
Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro systemTatsuaki Tagami, Mark J Ernsting, Shyh-Dar Li
Journal of Biomedical Materials Research. Part A|June 15, 2007
Human monocyte adhesion onto RGD and PHSRN peptides delivered to the surface of a polycarbonate polyurethane using bioactive fluorinated surface modifiersMark J Ernsting, Rosalind S Labow, J Paul Santerre
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 1, 2013
Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticlesMark J Ernsting, Mami Murakami, Aniruddha Roy, et al.
Biomaterials|March 31, 2015
A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumorsAniruddha Roy, Mark J Ernsting, Elijus Undzys, et al.
Molecular Pharmaceutics|October 25, 2013
Thermosensitive liposomes for the delivery of gemcitabine and oxaliplatin to tumorsJonathan P May, Mark J Ernsting, Elijus Undzys, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 17, 2012
A thermosensitive liposome prepared with a Cu²⁺ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacyTatsuaki Tagami, Jonathan P May, Mark J Ernsting, et al.
Bioconjugate Chemistry|October 22, 2011
Synthetic modification of carboxymethylcellulose and use thereof to prepare a nanoparticle forming conjugate of docetaxel for enhanced cytotoxicity against cancer cellsMark J Ernsting, Wei-Lun Tang, Noah MacCallum, et al.
International Journal of Pharmaceutics|May 24, 2014
Docetaxel-carboxymethylcellulose nanoparticles display enhanced anti-tumor activity in murine models of castration-resistant prostate cancerBryan Hoang, Mark J Ernsting, Mami Murakami, et al.
Biomaterials|November 15, 2011
Preclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse modelsMark J Ernsting, Wei-Lun Tang, Noah W MacCallum, et al.
Pageof 3